Mesoporous Silica-Encapsulated Cerium Oxide Nanozymes and Quercetin for Synergistic ROS-Modulated Downregulation of Inflammatory Cytokines
International Journal of Nanomedicine · 2025
DOI: 10.2147/ijn.s525411 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Shanlei Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, People's Republic of China. Hauptthemen laut MEDLINE: Cerium, Quercetin, Silicon Dioxide, Cytokines. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Introduction
Combining natural antioxidants with nanozymes represents a promising strategy to enhance therapeutic outcomes in oxidative stress-related diseases. This study integrates quercetin (Que), a plant-derived flavonoid with strong antioxidant activity, and cerium oxide nanozymes (CeO2NZs) into mesoporous silica (mSiO2) to enhance therapeutic efficacy and overcome the poor solubility and bioavailability of natural antioxidants.
Methods
Large-pore mSiO₂ (11 nm) were synthesized via a sol-gel method to encapsulate cerium oxide nanozymes (CeO₂NZs). Que was loaded using solvent impregnation to obtain (CeO₂/Que)@mSiO₂ nanocomposites. Structural and chemical characterization was performed, and biological evaluations were conducted in A549 cells.
Results
The incorporation of a large mesopore mSiO₂ (11 nm) significantly enhanced Que loading capacity and its sustained release in cell culture media. The (CeO₂/Que)@mSiO₂ nanocomposite demonstrated excellent biocompatibility, effective ROS scavenging, and significant downregulation of inflammatory cytokines (IL-1β, IL-6, TNF-α) compared to free Que.
Conclusion
The (CeO₂/Que)@mSiO₂ nanoplatform offers synergistic antioxidant and anti-inflammatory effects, supporting its potential for treating oxidative stress-related inflammatory conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, People's Republic of China.
- Premium Research SL, Guadalajara, 19003, Spain.
- Materials Science Institute of Barcelona (ICMAB-CSIC), Bellaterra, 08193, Spain.
- CDB, Hospital Clínic of Barcelona, IDIBAPS, CIBEREHD, Barcelona, Spain.
- Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, 08036, Spain.
- State Key Laboratory of Rare Earth Resources Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, People's Republic of China.
ORCID-Profile: Eudald Casals, Muling Zeng
Zitieren
APA
Zhou, S., Zhang, Y., Casals, E., Zeng, M., Morales-Ruiz, M., Liu, Q., Zhang, B., & Casals, G. (2025). Mesoporous Silica-Encapsulated Cerium Oxide Nanozymes and Quercetin for Synergistic ROS-Modulated Downregulation of Inflammatory Cytokines. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s525411
Vancouver
Zhou S, Zhang Y, Casals E, Zeng M, Morales-Ruiz M, Liu Q, et al. Mesoporous Silica-Encapsulated Cerium Oxide Nanozymes and Quercetin for Synergistic ROS-Modulated Downregulation of Inflammatory Cytokines. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s525411
BibTeX
@article{Zhou2025,
author = {Zhou, Shanlei and Zhang, Yu and Casals, Eudald and Zeng, Muling and Morales-Ruiz, Manuel and Liu, Qingshi and Zhang, Bo and Casals, Gregori},
title = {Mesoporous Silica-Encapsulated Cerium Oxide Nanozymes and Quercetin for Synergistic ROS-Modulated Downregulation of Inflammatory Cytokines},
journal = {International Journal of Nanomedicine},
year = {2025},
doi = {10.2147/ijn.s525411}
}
EUVIMED